Footprinting, circular dichroism and UV melting studies on neomycin B binding to the packaging region of human immunodeficiency virus type-1 RNA

Nucleic Acids Research

Volumn 30, Issue 13, 2002, Pages 2825-2831

  McPike, Mark P ^a   Sullivan, Julie M ^a   Goodisman, Jerry ^a   Dabrowiak, James C ^a  

^a SYRACUSE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; FRAMYCETIN; NUCLEOTIDE; PANCREATIC RIBONUCLEASE; VIRUS RNA;

ARTICLE; BINDING AFFINITY; BINDING SITE; CIRCULAR DICHROISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING; DRUG SPECIFICITY; HUMAN IMMUNODEFICIENCY VIRUS 1; MEASUREMENT; MELTING POINT; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOOTPRINTING; RNA STRUCTURE; STRUCTURE ANALYSIS; TEMPERATURE MEASUREMENT; ULTRAVIOLET SPECTROPHOTOMETRY; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0036639381     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkf402     Document Type: Article

References (29)

1. Targeting RNA with small molecules
2. Targeting RNA with small-molecule drugs: Therapeutic promise and chemical challenges
3. Strategies for the design of drugs targeting RNA and RNA-protein complexes
4. Aminoglycoside-RNA interactions
5. Modulation of RNA function by aminoglycoside antibiotics
6. Effect of mutations in the A site of 16S rRNA on aminoglycoside antibiotic-ribosome interaction
7. Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site
8. Saccharide-RNA recognition in a compex formed between neomycin B and a RNA aptamer
9. Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics
10. Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B
11. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy
12. Binding of dimeric aminoglycosides to the HIV-1 Rev responsive element (RRE) RNA construct
13. Aminoglycoside binding to human and bacterial A-site rRNA decoding region constructs
14. Inhibitors of protein-RNA complexation that target the RNA: Specific recognition of human immunodeficiency virus type-1 TAR RNA by small organic molecules
15. 2-Aminopurine as a real time probe of enzymatic cleavage and inhibition of hammerhead ribozymes
16. RNA-aminoglycoside antibiotic interactions: Fluorescence detection of binding and conformational change
17. Drug-RNA footprinting
18. Absorption studies on aminoglycoside binding to the packaging region of human immunodeficiency virus type-1
19. Footprinting and circular dichroism studies on paromomycin binding to the packaging region of human immunodeficiency virus type-1
20. RNA secondary structure and binding sites for gag gene products in the 5′ packaging signal of human immunodeficiency virus type 1
21. Retroviruses
22. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure
23. The major HIV-1 packaging signal is an extended bulged stem loop whose structure is altered on interaction with the Gag polyprotein
24. Monomer-dimer equilibrium constants of RNA in the dimer initiation site of human immunodeficiency virus type-1
25. Lai RNA dimerization process in vitro
26. Structural RNA mimetics: N3′→P5′ phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides
27. Binding of aminoglycoside antibiotics with modified A-site 16S rRNA construct containing non-nucleotide linkers
28. Specificity in the binding of aminoglycosides to HIV-RRE RNA
29. Thermodynamics of RNA unfolding: Stabilization of a ribosomal RNA tertiary structure by thiostrepton and ammonium ion